Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elizabeth Cohen

Showing results (101-110 of 108) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 108 results.
Neuro-Oncology Advances|May 31, 2021
Characteristics of diffuse hemispheric gliomas, H3 G34-mutant in adultsThiébaud Picart, Marc Barritault, Delphine Poncet, et al.
The Oncologist|May 17, 2023
Hypofractionated Stereotactic Re-irradiation and 
Anti-PDL1 Durvalumab Combination in Recurrent Glioblastoma: STERIMGLI Phase I ResultsDamien Pouessel, Soléakhéna Ken, Valérie Gouaze-Andersson, et al.
Frontiers in Oncology|December 11, 2023
Immune changes in hilar tumor draining lymph nodes following node sparing neoadjuvant chemoradiotherapy of localized cN0 non-small cell lung cancerJonathan Khalifa, Noémie Thébault, Clara-Maria Scarlata, et al.
Neuro-Oncology|July 7, 2023
Randomized phase III trial of metabolic imaging-guided dose escalation of radio-chemotherapy in patients with newly diagnosed glioblastoma (SPECTRO GLIO trial)Anne Laprie, Georges Noel, Leonor Chaltiel, et al.
BMC Cancer|February 23, 2019
Dose-painting multicenter phase III trial in newly diagnosed glioblastoma: the SPECTRO-GLIO trial comparing arm A standard radiochemotherapy to arm B radiochemotherapy with simultaneous integrated boost guided by MR spectroscopic imagingAnne Laprie, Soléakhéna Ken, Thomas Filleron, et al.
The Lancet. Oncology|May 10, 2017
European Association for Neuro-Oncology (EANO) guideline on the diagnosis and treatment of adult astrocytic and oligodendroglial gliomasMichael Weller, Martin van den Bent, Jörg C Tonn, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 2, 2024
Survival Outcomes Associated With First-Line Procarbazine, CCNU, and Vincristine or Temozolomide in Combination With Radiotherapy in IDH-Mutant 1p/19q-Codeleted Grade 3 OligodendrogliomaSalah Eddine O Kacimi, Caroline Dehais, Loïc Feuvret, et al.
Nature Medicine|April 12, 2022
Stratification of radiosensitive brain metastases based on an actionable S100A9/RAGE resistance mechanismCátia Monteiro, Lauritz Miarka, María Perea-García, et al.
Pageof 11

Showing results (101-110 of 108) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 108 results.
Neuro-Oncology Advances|May 31, 2021
Characteristics of diffuse hemispheric gliomas, H3 G34-mutant in adultsThiébaud Picart, Marc Barritault, Delphine Poncet, et al.
The Oncologist|May 17, 2023
Hypofractionated Stereotactic Re-irradiation and 
Anti-PDL1 Durvalumab Combination in Recurrent Glioblastoma: STERIMGLI Phase I ResultsDamien Pouessel, Soléakhéna Ken, Valérie Gouaze-Andersson, et al.
Frontiers in Oncology|December 11, 2023
Immune changes in hilar tumor draining lymph nodes following node sparing neoadjuvant chemoradiotherapy of localized cN0 non-small cell lung cancerJonathan Khalifa, Noémie Thébault, Clara-Maria Scarlata, et al.
Neuro-Oncology|July 7, 2023
Randomized phase III trial of metabolic imaging-guided dose escalation of radio-chemotherapy in patients with newly diagnosed glioblastoma (SPECTRO GLIO trial)Anne Laprie, Georges Noel, Leonor Chaltiel, et al.
BMC Cancer|February 23, 2019
Dose-painting multicenter phase III trial in newly diagnosed glioblastoma: the SPECTRO-GLIO trial comparing arm A standard radiochemotherapy to arm B radiochemotherapy with simultaneous integrated boost guided by MR spectroscopic imagingAnne Laprie, Soléakhéna Ken, Thomas Filleron, et al.
The Lancet. Oncology|May 10, 2017
European Association for Neuro-Oncology (EANO) guideline on the diagnosis and treatment of adult astrocytic and oligodendroglial gliomasMichael Weller, Martin van den Bent, Jörg C Tonn, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 2, 2024
Survival Outcomes Associated With First-Line Procarbazine, CCNU, and Vincristine or Temozolomide in Combination With Radiotherapy in IDH-Mutant 1p/19q-Codeleted Grade 3 OligodendrogliomaSalah Eddine O Kacimi, Caroline Dehais, Loïc Feuvret, et al.
Nature Medicine|April 12, 2022
Stratification of radiosensitive brain metastases based on an actionable S100A9/RAGE resistance mechanismCátia Monteiro, Lauritz Miarka, María Perea-García, et al.
Pageof 11